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Abstract
Background and Aim: To investigate the quality of and reasons for referrals of
patients with likely functional gastrointestinal disorders (FGID) and explore patients’
experience of clinical management.
Methods: A cross sectional, mixed-methods study was undertaken. Referrals (July
2013–2015) to one gastroenterology outpatient department triaged as “likely FGID”,
the referred patients and their referring primary healthcare providers were examined.
Results: A total of 69% of patients reported not yet receiving an initial diagnosis,
52% reported persistent/distressing symptoms or reduced quality of life, 24% feared
missed or worsening pathology, and 35% were seeking repeat specialist consultation.
Most patients were dissatisﬁed (40%) or only partially satisﬁed (36%) with current
management. Dissatisfaction was signiﬁcantly related to the lack of provision of a
diagnosis and effective treatment options (P < 0.001). Referral quality was poor and
with the reason for referral clearly communicated in only 25%. Common referral rea-
sons included repeat presentations (n = 32), diagnostic uncertainty (n = 19), to ensure
nothing is missed (n = 19), patient request (n = 17), no response to treatment
(n = 16), and to allay patient fears (n = 14). A total of 28/60 primary healthcare pro-
viders were conﬁdent that their patient had a FGID, yet sought conﬁrmation (n = 16),
second opinion (n = 8), or advice (n = 4).
Conclusion: Current management of FGID in usual care is suboptimal, as evidenced
by the tertiary referral load, patient dissatisfaction, and the lack of provision of diag-
noses and effective treatment options. Some clinicians lack conﬁdence in effectively
identifying and managing these conditions. Resources and supports to equip and assist
clinicians to identify and manage FGID successfully may enhance patient care.
Introduction
Globally, functional gastrointestinal disorders (FGIDs) pose a signif-
icant and growing public health problem.1 It is estimated that 40%
of the population will be affected by one or more FGIDs within
their lifetime, with irritable bowel syndrome (IBS) and functional
dyspepsia the most common.1,2 These chronic, recurrent conditions
impair quality of life and present a signiﬁcant economic cost due to
ongoing patient distress, unnecessary investigations, repeated health-
care visits, and workplace impairment.1,3 In 2000, an estimated $US
41 billion was spent on IBS alone in the UK, Japan, Australia, Swe-
den, Germany, France, and Canada.4
Historically, FGIDs were regarded as diagnoses of exclusion,
leading to unnecessary investigations,5 but can now be positively
diagnosed based on symptoms, red ﬂag exclusion and simple, and
relevant exclusionary tests.6–10 The UK’s National Institute of Clini-
cal Excellence recommend FGID be diagnosed and managed within
primary care and referred to gastroenterology after 1 year if disturb-
ing symptoms persist.11 However, most clinicians (72%) still regard
IBS as a diagnosis of exclusion.12 Few primary healthcare providers
(PHCPs) are aware of (2–36%) or use (0–21%) FGID diagnostic
criteria and 4–40% of cases are referred to specialist care13 (11% in
Australia).14 Variability in primary care management is reﬂected in
individual PHCP referral rates ranging 1–80%,15 with FGID refer-
rals accounting for 30–50% of gastroenterology consultations.16,17
In the Australian health system, gastroenterologist consultation can-
not be accessed without referral from PHCPs. Furthermore, referrals
to public gastroenterology outpatient clinics are triaged according to
clinical urgency, and those with clinically suspected functional gas-
trointestinal symptoms are deferred to very long waiting lists, with
many patients never being seen.18
Limited health resources and large open-ended referral
loads have frustrated patients, PHCPs and gastroenterologists
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alike. Understanding what drives referrals is essential to addres-
sing this growing public health problem. This study aimed to
describe the quality and drivers of referrals for patients with
likely FGID, and explore patient experience of clinical manage-
ment in the context of Australian health care.
Methods
This cross-sectional, mixed-methods study is nested within a con-
trolled pilot trial of an algorithm-based approach to the diagnosis
and management of FGID.19 All patients (18–75 years) referred
to one gastroenterology outpatient department (June 2013–July
2015) in a tertiary referral center (metropolitan city of 1.3 million
people), triaged as “likely FGID” with chronic or recurrent epi-
gastric/abdominal pain with or without altered bowel habit (diar-
rhea, constipation or both), bloating, nausea and vomiting, and
the absence of red ﬂags, were invited (n = 382) (Fig. 1). Patients
were excluded where the referral indicated predominant reﬂux
symptoms, evidence of current Helicobacter pylori infection,
positive fecal occult blood test or recent symptom onset
(<6 months), pregnancy, cognitive impairment or poor English
communication skills. Participants completed a demographic sur-
vey (n = 110) and those randomized to the algorithm group (2:1
ratio, sequentially) completed an additional structured medical
history questionnaire (n = 90). Referring PHCPs (of algorithm
group) were invited to complete a patient-speciﬁc, anonymous
questionnaire comprising open-ended and multiple-selection
questions regarding reasons for referral and conﬁdence in
diagnosing FGID. Patient symptom severity was measured by the
Gastrointestinal Symptom Rating Scale20 across ﬁve dimensions
on a 7-point Likert scale with seven being the most negative.
Data analysis. Referral quality was assessed with content
analysis, following the steps outlined by Neuendorf.21 Coding
categories assessed corresponded to routine referral triage criteria
and were prospectively deﬁned by a Senior Gastroenterologist
(JMA). These included legibility, clear reason for referral, inclu-
sion of relevant patient demographics (age, gender), medical
information (symptoms, symptom duration, clinical alarms, pro-
visional diagnosis), comorbidities (psychological and medical),
psychosocial history and its relevance to symptoms. A set of
10 referrals were analyzed by two independent coders (EL, MS),
coding compared and ﬁnal categories/rules decided by consensus
between all investigators. In total, 90 referrals were coded and
frequencies recorded. Referral codes were veriﬁed back to the
raw data (EL) to ensure coding consistency. Referral data were
compared to patient questionnaire responses, and discrepancies
corrected by consensus (MS, EL).
Open-form responses from both patient and PHCP ques-
tionnaires were also subject to content analysis (EL, JMA).
Where appropriate, codes were combined to explore over-arching
themes in the responses. Data were analyzed using SPSS 24
(IBM Corp., Armonk, NY, USA). Mean and SD or median and
interquartile range (IQR) were reported for ordinal data. Pear-
son’s Chi-square test of association was conducted where appro-
priate, with signiﬁcance ≤0.05.
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Figure 1 Flowchart of participant selection. FGID, functional gastrointestinal disorders; PCHP, primary healthcare provider.
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Ethics approval. This protocol received Human Research
Ethics Approval. All participants received an information sheet,
were given the opportunity to ask further questions by telephone
prior to intake, and gave informed consent. Trial registration:
ANZCTR, ACTRN12614000602628.
Results
Patient description
Demographics. Patients who completed the intake survey
(n = 110, Fig. 1) were 64% female, 54% married/de facto, with
mean age 42 years (SD 15). The median time on waitlist was
113 days (IQR 69–217). Most were in paid employment (24%
part-time, 37% full-time) and had completed high school or fur-
ther education (80%) (Table 1). Nonresponders were comparable
to responders in age, gender, and time on waitlist.
Symptom duration was greater than 2 years in 69% (24%
>10 years) of patients. A gastroenterologist had been previously
consulted in 35% of patients (53% of these, more than once) and
25% of patients had presented to hospital (79% of these, more
than once) for their gastrointestinal symptoms. A third of the
repeat-consulters (14/38) had seen the gastroenterologist within
the past 2 years. Medical and psychological comorbidities were
common (56% and 40%, respectively). First-time and repeat spe-
cialist consulters were comparable in age, gender, relationship
and employment status, and presence of medical and psychologi-
cal comorbidities. However, repeat consulters had a signiﬁcantly
longer symptom duration (Mean = 20.7 years, SD 29.6) than
ﬁrst-time consulters (Mean = 5.6 years, SD 12.8, t(105) = 3.699,
P < 0.001). Six patients in the algorithm group were diagnosed
with organic disease following the algorithm-based screening tests
(two inﬂammatory bowel disease, one neoplasm, one pancreatic
insufﬁciency, one reﬂux esophagitis, one dietary iron deﬁciency).
Health characteristics. The majority (78%) of patients were
using ≥1 treatment with little or no symptomatic improvement in
69% of these. In the previous 4 weeks, 60% had presented to
their PHCP (61% of these gastrointestinal-related) and 3% to the
Emergency Department. A total of 67% of patients had spent
from $5 to $1000 (median $45, IQR $23–$100) on treatment in
the previous 4 weeks. One spent over $1000 ﬂying interstate to
seek medical help from a gastroenterologist perceived to have
greater expertise and two commented on a lack of funds for treat-
ment (“I don’t have much money to spend” Patient 73, “$12 for
scripts. No other because of lack of funds” Patient 104). Allied
health professionals were consulted by 14% of patients within
the previous 4 weeks, with an average cost of $90 (IQR $63–
$263). Three patients had not spent money on allied health
because they had “given up” (Patients 55, 87) or seen “little or
no effect” (Patient 83), and a few indicated that they “cannot
afford” allied health (Patients 75, 90).
Overall, patient satisfaction with symptoms was low
(median = 3, IQR 1–5) varying along a 10-point Likert scale
(lower values indicating lesser satisfaction). Persistent/distressing
symptoms were reported by 38% of patients, and an additional 8%
experienced reduced quality of life (Fig. 2). At intake, 19 (17%)
reported few or no symptoms and attributed this to variability in
their symptom presentation. Symptom severity (Gastrointestinal
Table 1 Personal and clinical demographics of patients referred with suspected FGID (n = 110)
Personal Demographics All patients (n = 110) n (%) Prior Gastroenterologist Consultation
No (n = 72) Yes (n = 38)
n (%) n (%)
Gender Female 71 (64) 46 (64) 24 (63)
Primary language English 98 (89) 63 (88) 35 (92)
Relationship status Married/De facto 60 (54) 40 (56) 20 (73)
Employment status Full-time (>35 h/week) 41 (37) 28 (39) 13 (34)
Part-time (<35 h/week) 27 (24) 16 (22) 11 (29)
Education level Year 11 or below 23 (21) 15 (21) 8 (21)
Year 12 22 (20) 15 (21) 6 (16)
Higher education 66 (60) 42 (58) 24 (63)
Clinical Demographics
Symptom satisfaction score reason Persistent/distressing symptoms 42 (38) 28 (39) 14 (37)
Symptoms currently ok 22 (21) 17 (24) 5 (13)
Quality of life severely impacted 9 (8) 6 (8) 3 (8)
No diagnosis or management 5 (5) 4 (6) 1 (3)
Ok when medicated only 4 (4) 2 (3) 2 (5)
Fear it could be something serious 2 (2) 1 (1) 1 (3)
No reason given 26 (24) 14 (19.4) 12 (11)
Diagnosed by referring PHCP 34 (31) 18 (25) 16 (42)
Satisfaction with management Well satisﬁed 12 (11) 6 (8) 6 (16)
Satisﬁed 22 (20) 18 (25) 4 (11)
Partially satisﬁed 36 (33) 23 (32) 13 (34)
Unsatisﬁed 40 (36) 25 (35) 15 (40)
Medical comorbidities reported 61 (56) 41 (57) 20 (53)
Psychological comorbidities reported 44 (40) 29 (40) 15 (40)
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Symptom Rating Scale) cohort results were: diarrhea syndrome
median = 2 (IQR 1–4), indigestion syndrome median = 3 (IQR
2–4) constipation syndrome median = 2 (IQR 2–4), abdominal pain
syndrome median = 3 (IQR 2–4), reﬂux syndrome median = 2
(IQR 1–3). First-time and repeat gastroenterologist consulters were
comparable in symptom severity, symptom satisfaction, symptom
response to current treatment, as well as healthcare utilization and
cost of treatment over the past 4 weeks.
Patient reported description of management. Most
patients reported not having been given a diagnosis by their
PHCP (76/110, 69%), whilst 18% reported provisional diagnoses
of IBS (20/110; 8 being uncertain) and 4% (5/110) reﬂux-related
disorders. Similarly, nearly half who previously consulted a
gastroenterologist reported not receiving a diagnosis (18/38)
(Table 2). The most common specialist diagnoses acknowledged
included IBS (n = 9; 2 being uncertain) and reﬂux/gastritis (n = 4)
with three patients unable to recall the diagnosis. Patients
expressed concern about painful/distressing symptoms (37%) and
fear of missed serious pathology or symptom progression to some-
thing more serious (24%) (Table S1, Supporting information).
Satisfaction with management. Patient satisfaction with
management at intake was poor: 40% dissatisﬁed and 36% only
partially satisﬁed, with no difference between ﬁrst-time and
repeat consulters (Fig. 2). Only 12 patients reported being well
satisﬁed. The lack of provision of a diagnosis, lack of effective
treatment options, frustration with the “system”, and the belief
that further investigations were needed emerged as themes in
patients’ responses regarding management (Table 3). Dissatis-
faction was signiﬁcantly related to the “lack of provision of a
diagnosis/treatment options” (χ2(33) = 76.985, P < 0.001),
with 33% of partial/fully dissatisﬁed patients reporting lack of
diagnosis. In addition, 16% of dissatisﬁed patients were satis-
ﬁed with their PHCP but awaited a specialist appointment,
12% reported ineffective management options and 12% dissat-
isfaction with PHCP.
Description of referrals
Proﬁle of referring PHCPs. Referral quality was assessed for
patients allocated to the algorithm group who completed the
intake survey (n = 100, Fig. 1); 89 were unique referrals from
78 PHCPs in 60 practices, 11 were referrals from other units
within the hospital. Of the 90 PHCP requests (to 78 PHCPs) to
complete a patient-speciﬁc survey, 61 (68%) responded
(36 males); 42/61 were at least 40 years of age and 50/61 has
6 or more years’ experience as a primary healthcare physician
(n = 39 > 10 years, 23 > 20 years).
Referral quality. Overall, referral quality was poor; 6% were
poorly legible, and many lacked basic information such as patient
age (49%), gender (27%), symptom duration (50%), smoking sta-
tus (96%), alcohol history (94%), and medical (33%), and psy-
chological (84%) comorbidities. Issues related to mental health
and alcohol appeared to be automatically generated and were not
integrated into referral narrative.
Clinical alarms were not considered in 71% of referrals.
Alarms were consistently underreported when compared to
patient responses from the structured health questionnaire
(Fig. 3). Provisional diagnoses and clear reasoning for the refer-
ral were not provided in 68% and 75% of referrals, respectively.
Endoscopies were requested in 33% of referrals and 40% of these
failed to provide a reason for the request.
Reasons for referral. Despite comment from one PHCP that
“there is usually a very good reason to refer to a consultant;
unavailability of an investigation, uncertainty of diagnosis,
patient anxiety etc.”, reasons were clearly communicated in only
25% of referrals (Fig. 4). The most common reason stated in
the referral was to request investigations or patient request.
When directly asked for the reason for the referral, a third of
PHCPs did not provide a rationale for the referral; 16 simply
relisted the symptoms and 4 declined to answer. Where reasons
12
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40
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Satisfied
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Unsatisfied
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9
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Figure 2 Clinical demographics of patients referred with suspected
FGID. , No prior GE consult; , prior GE consult.
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were stated, common reasons included: persistent symptoms,
request for endoscopic procedure, inability to reach a diagnosis
and conﬁrmation of diagnosis. Other reasons selected from a
structured list included to ensure nothing is missed, nonre-
sponse to treatment, allay patient fears and inability to meet
patients demands.
Approximately half the PHCPs (28/60) were conﬁdent that
their patient had a FGID in response to the forced multiple
choice question “Based on your current investigations, are you
conﬁdent that this patient has a functional gastrointestinal disor-
der?”. Of these, 16 sought conﬁrmation of the diagnosis, 4 treat-
ment advice and 8 a second opinion at patient request. A third
Table 2 Patient reported existing or provisional diagnoses
Reported diagnosis
Total
n = 110
Patients who had not seen a
specialist n = 72
Patients with prior gastroenterologist
consult n = 38
No diagnosis given 69 (63) 54 (75) 18 (47)
IBS 11 (10) 6 (8) 7 (18)
Possible IBS 8 (7) 5 (7) 2 (5)
IBS plus other 3 (3)
Reﬂux/heartburn/dyspepsia/gastritis 3 (3) 1 (1) 4 (11)
Possible peptic/gastric ulcer 2 (2) 2 (3)
Gastric ulcer 1 (1) 1 (1)
Diagnosis not reported by patient 2 (2) 2 (5)
Gallstones 1 (1) 1 (1)
Possible gallstones 1 (1)
Fatty liver 1 (1) 1 (3)
“Collapsed colon” and fatty liver 1 (1) 1 (1)
Diverticulosis 1 (1)
HP Infection 2 (2) 1 (3)
“A ﬂoppy valve-esophagus” 1 (1) 1 (3)
“Hemorrhoids, narrow colon near
anus”
1 (1) 1 (3)
Hiatus hernia 1 (1) 1 (3)
Lactose intolerance/? underlying
issue
1 (1) 1 (1)
FGID, functional gastrointestinal disorders; PHCP, primary healthcare provider.
Table 3 Themes of patient response to satisfaction with management
Theme Example
No diagnosis and/or
management
• “… has offered no assistance, has told me I need to learn to live with it”
• “Have no diagnosis, nor any idea how to treat it”
• “I…was only given pain relief which seems to put a Band-Aid on the problem but has not solved why, or
what is causing the problem”
• “I’ve seen different PHCP’s and at this stage, all they have been able to offer me are various tests. This has
been going on for a few years”
Frustration • “My PHCP is trying his best but now I can’t afford private health insurance I am on long public waitlists
when I am extremely ill”
• “Long waiting lists, difﬁculty getting started / getting healthcare going”
• “No results, constant hand balling. Ultimately no relief and now on a 12-month waiting list for the next step”
• “She tries her best; it is not her fault that the system is completely broken”
• “The public system sucks”
Belief that further investigations
are needed
• “My current doctor has done all he can but because I haven’t had an endoscopy or colonoscopy he can’t
really do much”
• “I am still not fully diagnosed, therefore I am concerned to know what my health problem is and how to
manage it”
• “PHCP has investigated with no success then referred to specialist, have not seen a specialist yet”
• “I doubt my PHCP knew it would be this long and still no colonoscopy. I hope once I have this we can plan
treatment”
• “To cover all bases, she sent me to have an ultrasound, which came back clear. Next step was obviously to
have the colonoscopy but the way it looks I won’t be seen for a long time. I wish she had another idea of
what it could be and how to investigate it but it seems not...pity”
PHCP, primary healthcare provider.
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(27/60) indicated that they were “unsure” (n = 20) or “not conﬁ-
dent” (n = 7) and would like advice. One PHCP commented “I
am very happy to manage functional GIT disorders and would
not refer these to a GI unit unless I felt a SOL [space-occupying
lesion] needed exclusion”. Five PHCPs were conﬁdent of an
alternative organic diagnosis (although three could not suggest
what this was).
Discussion
The referrals, and PHCP and patient surveys provide a novel,
multi-faceted window into the real-world management of FGIDs
in Australia. The use of both qualitative and quantitative analyses
yields rich information on patient and practitioner perspectives to
help better explain how and why the model of care for this
highly prevalent group of disorders needs changing. The delivery
of better quality care is important to the patient and community
given the high prevalence, morbidity, and cost of these disorders.
This study identiﬁes four important issues which represent oppor-
tunities to improve the management of FGIDs: (i) patient dissat-
isfaction with management despite recent PHCP consultation or
previous gastroenterologist consultation; (ii) the lack of provision
(and/or acceptance (22)) of a clear diagnosis to patients (in both
primary and tertiary care); (iii) low real-world conﬁdence of
some clinicians in diagnosing and communicating a FGID diag-
nosis; and (iv) poor referral quality reducing triage safety.
Whilst patient-reported symptoms might be considered
subjective and exaggerated, (particularly in FGID with high rates
of anxiety and/or depression), patient satisfaction with care is a
valid and important indicator of effective management. A signiﬁ-
cant proportion of patients were dissatisﬁed with both primary
and tertiary care management. Dissatisfaction was related to the
lack of diagnosis and treatment options and is a potential driver of
repeat consultation. Our ﬁndings are consistent with previous stud-
ies describing the dissatisfaction of patients with FGIDs with the
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healthcare system.22,23 Those studies found that patients felt aban-
doned by healthcare and received inadequate information about
their disorder and how to manage their symptoms.22,23 The expec-
tations and experience of patients with FGID with the clinical con-
sultation often differ from those of the clinician.24,25 Patients place
a high value on being able to understand their condition following
the consult, as well as the care and concern of their doctor.24,26
The provision of a clear, timely, accurate diagnosis is
recommended to move patients from a prolonged diagnostic
search to an effective management pathway. The reported lack of
diagnosis may be due to a number of factors, such as poor
patient recall, patient nonacceptance of a functional diagnosis,25
or poor communication of diagnosis by the clinician.27 Although
this study cannot distinguish between lack of recall and lack of
actual diagnosis, poor recall is less likely as patients were willing
to report “unsure” or “possible” IBS diagnoses, which aligns
with previous ﬁndings that patients with medically unexplained
symptoms (such as FGIDs) often report many more diagnoses
than can be conﬁrmed.28 Patient reluctance to accept or acknowl-
edge a functional diagnosis has been previously documented.25,29
However, the lack of diagnostic documentation (neither provi-
sional nor conﬁrmed diagnoses) in the referrals supports the lack
of provision of a diagnosis rather than patient nonacceptance of a
functional diagnosis in this study.
Recent studies have shown that most clinicians continue to
regard IBS as a diagnosis of exclusion.12,30 Only 52% of gastroen-
terologists and 34% of PHCPs were conﬁdent diagnosing IBS
based on symptoms, history and physical exam, with less than half
of these conﬁdent to inform the patient without further investiga-
tions.12 This is also supported by the reluctance of PHCPs to add
IBS read-codes to patient records until more serious pathology
was excluded.31 Although FGIDs are largely managed in primary
care, this study together with the specialist FGID referral load sug-
gests that the real-world conﬁdence of clinicians in diagnosing
FGIDs and communicating in some instances is low.
A signiﬁcant proportion of PHCPs, referred for conﬁrma-
tion of a FGID diagnosis (not stated in referral), at the request of
the patients, or for further investigations. This is in keeping with
previous ﬁndings, that many clinicians may consider a functional
diagnosis but are reluctant to communicate this to the patient32
or to document it33 without further investigation. The PHCP
sample was slightly younger and less experienced than the
national average: 31% were under 40 years compared with 24%
under 44 years nationally; 43% had been in practice for more
20 years compared to 64%.34 As PHCP surveys were unidenti-
ﬁed, we were unable to explore whether lack of diagnostic conﬁ-
dence was related to age or experience. However, the paucity of
provisional diagnoses of IBS ﬂagged in the referrals, suggests
this problem crosses experience and age. PHCPs’ perception of
the necessity for further investigations in the absence of alarm
features was also reﬂected in the patients’ belief that they could
receive no diagnosis or treatment options until endoscopic proce-
dures were performed. The tertiary referrals analyzed may reﬂect
a cohort of clinicians who struggle to manage FGID, a particu-
larly difﬁcult patient group, or a complex symptom set.15,16
Although low conﬁdence in diagnosing and/or managing FGIDs
was found to be the main reason for these referrals, we cannot
however determine the contributing factors which led to the inabil-
ity to diagnose or manage these speciﬁc patients in primary care.
Paradoxically, although long-term nonprogressive symp-
toms are highly likely to be functional, chronic symptoms appear
to also be driving diagnostic uncertainty and desire for specialist
input to exclude other diagnoses and reassure patients. Although
specialist input is not unreasonable, current public health
resources cannot fund the demand. Consistent with this reality,
current guidelines recommend an initial diagnosis based on
symptomatology, followed up with simple investigations, prior to
receiving a clinical diagnosis of FGID,11,35 and National Institute
of Clinical Excellence guidelines recommend this occurs within
primary care.36 The incidence of organic disease detected upon
screening may reﬂect suboptimal screening within primary care,
or poor referral quality. In each of these cases, if the referral had
included relevant positive and negative alarm features (as per
usual guidelines for the clinical diagnosis of FGIDs) these refer-
rals would have initially received a high triage category and
patients seen promptly. Primary care clinical pathways for the
diagnosis and management of FGIDs, may help reduce referral
burden, assist in early, effective diagnosis and management and
ensure appropriate identiﬁcation of clinical alarms requiring
urgent gastroenterology review.
FGID management can be challenging. Persistent symptoms
that ﬂuctuate in severity or even change are not uncommon, with
patients rarely becoming totally symptom-free.37,38 There is, how-
ever, consensus on both the diagnostic and management approach
that should be taken. Further studies within primary care are needed
to ascertain PHCP awareness of how FGID should be diagnosed
and managed according to current best practice. Efforts to develop
locally relevant consensus and shared belief between primary and
tertiary care on best practice, and clinical pathways which promote
quality patient care are needed. An assessment of the quality and
availability of PHCP resources (e.g. online pathways, educational
sessions), opportunities to partner with specialists to develop and
deliver best practice approaches (which include referrals), and of
other barriers such as funding structures and access to FGID spe-
cialized allied health professionals will also inform where gains can
be made. With this and the data from the current study, the devel-
opment of FGID clinical pathways may streamline and optimize
patient care across primary and tertiary sectors.
The generalizability of these ﬁndings may be limited, as it
was conducted in one tertiary hospital. However, this appears
unlikely as a recent systematic review of 29 studies (Europe,
North America, Middle East; South East Asia) found 4–40% of
patients suspected of having FGID were referred for specialist
consultation,13 indicating that our referral load and management
problems are not unique. A strength of our study is the use of a
mixed methods approach to triangulate data from actual referrals,
referring PHCPs and the patients themselves, to gain a more
comprehensive understanding of FGID management.
Current FGID management is suboptimal, as evidenced by
the tertiary referral load, patient dissatisfaction, the lack of provi-
sion of diagnoses and effective treatment options, and long wait-
ing lists for specialist review. Some clinicians lack conﬁdence in
effectively identifying and managing these conditions, which
may stem from a lack of awareness of current best practice and
how to access evidence-based management options. Further
research into FGID management is needed to develop resources
such as clinical guidelines, pathways and structured online refer-
rals which may improve patient care.
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